Fc receptors are major mediators of antibody based inflammation in autoimmunity
- PMID: 12413532
- DOI: 10.1016/s0952-7915(02)00409-0
Fc receptors are major mediators of antibody based inflammation in autoimmunity
Abstract
There is now renewed interest in the role of antibodies in autoimmunity. Recent compelling evidence indicates that autoantibodies and the effector mechanisms they induce, for example, Fc receptor activation of leukocytes and/or the complement cascade, are central players in the development of autoimmunity, by perpetuating inflammation and perhaps even regulating the process itself. Of increasing interest are Fc receptors, which have been more closely investigated in the past decade using recombinant proteins, gene deficient mice and mouse models of human disease. These analyses point towards major roles of Fc receptors in antibody hypersensitivity reactions and by extension autoimmune disease, and they reveal opportunities in the development of novel therapeutic approaches in the treatment of autoimmune diseases.
Similar articles
-
Fc receptors and their interaction with complement in autoimmunity.Immunol Lett. 2005 Aug 15;100(1):56-67. doi: 10.1016/j.imlet.2005.06.022. Immunol Lett. 2005. PMID: 16125792 Review.
-
The impact of Fc receptors on the development of autoimmune diseases.Curr Pharm Des. 2003;9(23):1861-70. doi: 10.2174/1381612033454414. Curr Pharm Des. 2003. PMID: 12871190 Review.
-
Inflammation in autoimmunity: receptors for IgG revisited.Trends Immunol. 2001 Sep;22(9):510-6. doi: 10.1016/s1471-4906(01)02014-2. Trends Immunol. 2001. PMID: 11525942 Review.
-
IgG Fc receptors.Annu Rev Immunol. 2001;19:275-90. doi: 10.1146/annurev.immunol.19.1.275. Annu Rev Immunol. 2001. PMID: 11244038 Review.
-
The IgG Fc receptor family.Ann Hematol. 1998 Jun;76(6):231-48. doi: 10.1007/s002770050396. Ann Hematol. 1998. PMID: 9692811 Review.
Cited by
-
Paired immunoglobulin-like receptors and their MHC class I recognition.Immunology. 2005 Aug;115(4):433-40. doi: 10.1111/j.1365-2567.2005.02177.x. Immunology. 2005. PMID: 16011512 Free PMC article. Review.
-
Immunogenicity to Biotherapeutics - The Role of Anti-drug Immune Complexes.Front Immunol. 2016 Feb 2;7:21. doi: 10.3389/fimmu.2016.00021. eCollection 2016. Front Immunol. 2016. PMID: 26870037 Free PMC article. Review.
-
Translating basic mechanisms of IgG effector activity into next generation cancer therapies.Cancer Immun. 2012;12:13. Epub 2012 May 1. Cancer Immun. 2012. PMID: 22896758 Free PMC article. Review.
-
Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and "New Old Friends".Front Immunol. 2020 Sep 4;11:2059. doi: 10.3389/fimmu.2020.02059. eCollection 2020. Front Immunol. 2020. PMID: 33013871 Free PMC article. Review.
-
Glycosylation of Antigen-Specific Antibodies: Perspectives on Immunoglobulin G Glycosylation in Vaccination and Immunotherapy.Exp Suppl. 2021;112:565-587. doi: 10.1007/978-3-030-76912-3_18. Exp Suppl. 2021. PMID: 34687023
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous